Close Menu

NEW YORK (GenomeWeb) – Molecular diagnostics developer Luminex announced today that it has received clearance from the US Food and Drug Administration as well as CE-IVD marking for its in vitro diagnostic system, the Aries M1.

The M1 is a lower-throughout version of the company's Aries System, and is designed for use in smaller satellite labs. It extracts, amplifies, and detects nucleic acid targets from a variety of sample types, and can process up to six different samples and up to six PCR-based assays at a time.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.